DNM2 and urinary bladder carcinoma: In terms of intensity, membranous, cytoplasmic, and nucleus expressions of DNM2 were recognized in 182 (87.1%), 207 (99.0%), and 27 (12.9%) bladder cancer cases, respectively (Table 2).